Ishares Gen-immunology Hlth (IDNA) Technical Analysis
$19.70▲1.76%
Insights
- Ishares Gen-immunology Hlth is currently in a neutral trading position according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Ishares Gen-immunology Hlth stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Ishares Gen-immunology Hlth stock is in a downtrend↘️
- Based on analysis of the Pivot Points, the current market trend for Ishares Gen-immunology Hlth stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 42.53 | Neutral |
Stochastic | 60.59, 54.99 | Neutral |
Ultimate Oscillator | 57.11 | Neutral |
Stochastic Relative Strength Index | 94.05, 96.26 | Sell |
Moving Average Convergence Divergence | -0.71, -0.77 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 18.89 | Sell |
20 | 19.87 | Sell |
50 | 21.37 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 19.3 | Sell |
20 | 19.8 | Sell |
50 | 20.92 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 18.7 | Buy |
20 | 19.76 | Neutral |
50 | 21.09 | Sell |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 18.94 | Buy |
20 | 18.82 | Sell |
50 | 19.67 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 19.19 | Buy |
20 | 18.66 | Sell |
50 | 19.01 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 19.84 |
Resistance L2 | 19.64 |
Resistance L1 | 19.4 |
Pivot Point | 19.2 |
Support L1 | 18.96 |
Support L2 | 18.76 |
Support L3 | 18.52 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.